Lucy Rutten

Qserve Group (Netherlands)

Papers

1

Total Citations

46

H-Index

1

About

Dr. Lucy Rutten is a leading structural biologist and immunologist whose pioneering work on heavy chain-only antibodies (HCAb) from llamas has opened new frontiers in HIV-1 vaccine design. Her most cited study, "Molecular Evolution of Broadly Neutralizing Llama Antibodies to the CD4-Binding Site of HIV-1" (2014, 46 citations), demonstrated that immunization of llamas can elicit broadly neutralizing antibodies targeting the conserved CD4-binding site of HIV-1—a feat that traditional immunization in humans and other animals had failed to achieve. This landmark research revealed the unique molecular evolution of these compact antibodies, highlighting their potential to overcome HIV’s formidable immune evasion strategies. Dr. Rutten’s contributions have significantly advanced our understanding of how unconventional antibody formats can be harnessed for therapeutic and prophylactic applications against infectious diseases. Her work not only provides a blueprint for eliciting broadly neutralizing responses via immunization but also underscores the translational power of comparative immunology. By bridging structural biology and vaccinology, Dr. Rutten continues to inspire new strategies for tackling some of the most challenging pathogens, with her findings informing next-generation vaccine platforms and antibody-based therapeutics.

Research Focus

Key Achievements

1
H-Index
1
Papers
46
Total Citations
46
Avg Citations/Paper
🏆 Most Cited Paper
Molecular Evolution of Broadly Neutralizing Llama Antibodies to the CD4-Binding Site of HIV-1
46 citations · 2014
📈 Most Prolific Year: 2014 (1 Papers)
🤝 Key Collaborators: 15
🏛 Institutions: Qserve Group (Netherlands)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago